Market Cap (In EUR)
26.82 Million
Revenue (In EUR)
3.86 Million
Net Income (In EUR)
-10.63 Million
Avg. Volume
7679.00
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.88-19.5
- PE
- -
- EPS
- -
- Beta Value
- 4.493
- ISIN
- DE000A3E5A59
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Lars Muller
- Employee Count
- -
- Website
- https://www.synbiotic.com
- Ipo Date
- 2021-01-07
- Details
- SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.
More Stocks
-
CPTRCaptor Capital Corp.
CPTR
-
KLGDFKalo Gold Corp.
KLGDF
-
DHAMPUREDhampure Speciality Sugars Limited
DHAMPURE
-
TGOPY3i Group plc
TGOPY
-
ABBOTINDIAAbbott India Limited
ABBOTINDIA
-
002808
-
GSMLG&S Minerals, Inc.
GSML
-
018470Choil Aluminum Co., Ltd.
018470